Search

everythinglearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tridax procumbens may help treat diabetes.

A new compound effectively inhibits human 5α-reductase 1.

Netherton syndrome in a boy caused skin and hair issues, and treatment didn't work.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

ATP helps prevent skin damage from vandetanib by reducing stress.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Tofacitinib helped a woman regrow hair with no major side effects.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib helped regrow hair in a woman with alopecia areata.